Sugi Predict

Sugi Predict / Compounds / SCHEMBL360272

SCHEMBL360272

SCHEMBL360272

Cc1ccc(I)c(S(=O)(=O)O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.39
▸ GAA P10253 4/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ CASP6 P55212 1/20 0.39
▸ ELAVL1 Q15717 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ TSHR P16473 2/20 0.38
▸ MPL P40238 1/20 0.37
▸ HIF1A Q16665 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MYC P01106 1/20 0.35
▸ USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32679848 1.00 ALDH1A1 (0.39) ALDH1A1GAAKMT2AKDM4EPOLB
Potassium SCHEMBL2564722 0.98 ALDH1A1 (0.38) ALDH1A1GAAKMT2AKDM4EPOLB
SCHEMBL2564720 0.98 ALDH1A1 (0.38) ALDH1A1GAAKMT2AKDM4EPOLB
SCHEMBL24278496 0.83 ALDH1A1 (0.39) ALDH1A1GAAKMT2AKDM4EPOLB
SCHEMBL8959215 0.80 ALDH1A1 (0.42) ALDH1A1GAAKMT2AKDM4EPOLB
SCHEMBL3775205 0.79 KDM4E (0.52) ALDH1A1KMT2AKDM4EPOLBMEN1
SCHEMBL2840799 0.78 HPGD (0.34) ALDH1A1KMT2AKDM4EMEN1MAPT
SCHEMBL18066938 0.78 LMNA (0.50) ALDH1A1GAAPOLBRECQLCASP6
SCHEMBL197382 0.78 RAD51 (0.41) HSD17B10TSHRHIF1ALMNAHPGD
SCHEMBL11327329 0.78 MYC (0.41) ALDH1A1GAAKMT2AKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118852101-A Sulfonyloxy high-valence iodized salt and preparation method thereof 中国人民解放军军事科学院防化研究院 2024-10-29 — — CN disclosed
CN-110857265-B Process for preparing (E2) -cis-6, 7-epoxy-2-nonenal 信越化学工业株式会社 2023-05-16 — — CN disclosed
US-20220066319-A1 POSITIVE RESIST MATERIAL AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-03-03 — — US disclosed
US-10259794-B2 Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives CEPHALON, INC. (US) 2019-04-16 — — US disclosed
EP-3237408-B1 METHODS FOR PREPARING FUSED BICYCLIC 2, 4-DIAMINOPYRIMIDINE DERIVATIVES CEPHALON INC (US) 2018-10-31 — — EP disclosed
US-20170369451-A1 METHODS FOR PREPARING FUSED BICYCLIC 2, 4-DIAMINOPYRIMIDINE DERIVATIVES CEPHALON, INC. 2017-12-28 — — US disclosed
EP-3237408-A1 METHODS FOR PREPARING FUSED BICYCLIC 2, 4-DIAMINOPYRIMIDINE DERIVATIVES Cephalon, Inc. (US) 2017-11-01 — — EP disclosed
WO-2016105529-A1 METHODS FOR PREPARING FUSED BICYCLIC 2, 4-DIAMINOPYRIMIDINE DERIVATIVES CEPHALON, INC. (US) 2016-06-30 — — WO disclosed
EP-2638126-B1 NEGATIVE DISPERSION RETARDATION PLATE AND ACHROMATIC CIRCULAR POLARIZER CRYSOPTIX KK (JP) 2015-02-18 — — EP disclosed
EP-2638126-B1 NEGATIVE DISPERSION RETARDATION PLATE AND ACHROMATIC CIRCULAR POLARIZER CRYSOPTIX KK (JP) 2015-02-18 — — EP disclosed
WO-2012044867-A1 PATTERNED RETARDER CRYSOPTIX KK (JP) 2012-04-05 — — WO disclosed
WO-2012044867-A1 PATTERNED RETARDER CRYSOPTIX KK (JP) 2012-04-05 — — WO disclosed
US-20120081784-A1 PATTERNED RETARDER CRYSOPTIX KK (JP) 2012-04-05 — — US disclosed
WO-2012008981-A2 POLARIZER AND LIQUID CRYSTAL DISPLAY COMPRISING THE SAME CRYSOPTIX KK (JP) 2012-01-19 — — WO disclosed
WO-2012008981-A2 POLARIZER AND LIQUID CRYSTAL DISPLAY COMPRISING THE SAME CRYSOPTIX KK (JP) 2012-01-19 — — WO disclosed
US-20110149206-A1 Polarizer and Liquid Crystal Display Comprising the Same CRYSOPTIX KK (JP) 2011-06-23 — — US disclosed
US-20110149206-A1 Polarizer and Liquid Crystal Display Comprising the Same CRYSOPTIX KK (JP) 2011-06-23 — — US disclosed
US-20110149206-A1 Polarizer and Liquid Crystal Display Comprising the Same CRYSOPTIX KK (JP) 2011-06-23 — — US disclosed
US-20100041917-A1 PROCESS FOR PREPARATION OF CARBONYL COMPOUND AND PRO-OXIDANT FOR PREPARATION OF CARBONYL COMPOUND NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2010-02-18 — — US disclosed
EP-2085373-A1 METHOD FOR PRODUCING CARBONYL COMPOUND AN PRO-OXIDANT USED FOR PRODUCTION OF CARBONYL COMPOUND National University Corporation Nagoya University (JP) 2009-08-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369451-A1 METHODS FOR PREPARING FUSED BICYCLIC 2, 4-DIAMINOPYRIMIDINE DERIVATIVES DPYD, LIG4, CEP170 ALDH1A1 1904/4885GAA 3351/4885KMT2A 690/4885
US-20100041917-A1 PROCESS FOR PREPARATION OF CARBONYL COMPOUND AND PRO-OXIDANT FOR PREPARATION OF CARBONYL COMPOUND CBR1, CBR3, NOX4 ALDH1A1 39/4885GAA 4474/4885KMT2A 2063/4885
US-10259794-B2 Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives DPYD, LIG4, CEP170 ALDH1A1 1904/4885GAA 3351/4885KMT2A 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.